ABBOTT LABORATORIES 4
4 · ABBOTT LABORATORIES · Filed Mar 19, 2010
Insider Transaction Report
Form 4
OWEN DAVID
Director
Transactions
- Exercise/Conversion
Common shares without par value
2010-03-18$42.73/sh+5,616$239,987→ 17,704 total - Sale
Common shares without par value
2010-03-18$54.44/sh−100$5,444→ 13,988 total - Exercise/Conversion
Option (right to buy)
2010-03-18−5,616→ 0 totalExercise: $42.73From: 2001-04-27Exp: 2011-04-26→ Common shares (5,616 underlying) - Sale
Common shares without par value
2010-03-18$54.44/sh−100$5,444→ 24,017 total - Exercise/Conversion
Option (right to buy)
2010-03-18−6,413→ 0 totalExercise: $37.42From: 2003-04-25Exp: 2013-04-24→ Common shares (6,413 underlying) - Exercise/Conversion
Common shares without par value
2010-03-18$37.42/sh+6,413$239,993→ 24,117 total - Sale
Common shares without par value
2010-03-18$54.44/sh−9,929$540,535→ 14,088 total - Sale
Common shares without par value
2010-03-18$54.44/sh−1,900$103,438→ 12,088 total
Footnotes (1)
- [F1]Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.